PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.44%
R&D growth 0-5% reflects moderate investment. Benjamin Graham would check if spending drives future value.
34.62%
G&A growth above 5% signals concerning overhead expansion. Seth Klarman would demand justification for increased costs.
No Data
No Data available this quarter, please select a different quarter.
-26.41%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
14.45%
Operating expenses growth above 10% signals concerning cost expansion. Seth Klarman would demand justification.
14.45%
Total costs growth above 5% signals concerning expansion. Seth Klarman would demand justification.
561.32%
Interest expense growth above 10% signals concerning debt expansion. Seth Klarman would demand justification.
-26.41%
Negative D&A growth needs verification. Benjamin Graham would examine asset reduction strategy.
55.40%
EBITDA growth above 15% demonstrates exceptional operating performance. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-14.45%
Negative operating income growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
231.19%
Other expenses growth above 30% signals concerning expansion. Seth Klarman would scrutinize unusual items.
43.33%
Pre-tax income growth above 15% demonstrates exceptional profitability improvement. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
561.32%
Tax expense growth above 20% signals concerning expansion. Seth Klarman would scrutinize tax strategy.
43.33%
Net income growth above 15% demonstrates exceptional bottom-line expansion. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
43.35%
EPS growth above 15% demonstrates exceptional shareholder value creation. Warren Buffett would verify sustainability.
43.35%
Diluted EPS growth above 15% demonstrates exceptional value creation despite potential dilution. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.